Audit of practice in platelet refractoriness

Vox Sanguinis

Volumn 73, Issue 2, 1997, Pages 81-86

  Phekoo, K J ^a   Hambley, H ^b   Schey, S A ^a   Win, N ^c   Carr, R ^d   Murphy, M F ^e  

^a GUY S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c S Thames Blood Transfusion Service   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; LEUKOCYTE ANTIBODY; THROMBOCYTE ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BLEEDING; DISEASE CLASSIFICATION; HEALTH CARE COST; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE;

EID: 0030876482     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7320081.x     Document Type: Article

References (11)

1. Gmur J, Burger J, Schanz U, Fehr J, Scaffner A: Safety of prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991;338:1223-1226.
2. National Institutes of Health: Consensus development conference on platelet transfusion therapy. JAMA 1987;257:1777-1780.
3. Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzip GP: High-dose cytarabine and daunorubicin as consolidative therapy for acute myeloid leukaemia in first remission: Long term follow-up and results. J Clin Oncol 1989;7:1260-1267.
4. Adler SP: Cytomegalovirus and transfusions. Transfus Med Rev 1988;2:235-244.
5. Bucholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR Jr: Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1973;13:268- 275.
6. Waters AH, Michinton RM, Bell R, Ford JM, Lister TA: A crossmatching technique for the selection of donors for alloimmunised patients. Br J Haematol 1981;48:59-68.
7. Bishop JF, McGrath K, Wolf MM, Matthews JM, DeLuise T, Holdsworth R, Yuen K, Veale M, Whiteside MG, Cooper IA, Szer J: Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988;71:383-387.
8. Doughty HA, Murphy MF, Metcalfe P, Rohatiner AZS, Lister TA, Waters AH: Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 1994;66:200- 205.
9. Jorgenson DW, McFarland JG, Hillman RS, Slichter SJ: Plateletpheresis program. II. Computer selection of HLA compatible donors. Transfusion, 1984;4:292-298.
10. Friedberger RC, Donnelly SF, Mintz PD: Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunised patients. Transfusion 1994;34:215-220.
11. Bishop JF, McGrath K, Yuen K, Wolf MM, Szer J: Factors influencing 20 hour increments after platelet transfusion. Transfusion 1990;31:392- 396.